Initial clinical experience with ICI 141,292 (Visacor), a new selective beta 1-adrenoceptor blocker with ISA--a multicentre trial in 59 patients.

The objective of this placebo controlled double-blind multicentre (six centres) trial was to investigate the safety and efficacy of ICI 141,292 (Visacor), a new selective beta 1-adrenoceptor antagonist with modest intrinsic sympathomimetic activity (ISA), in hypertensive patients. Fifty-nine patient...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dahlöf, B, Danielson, M, Andersson, O, Thulin, T, Ohman, P, Mörlin, C, Boberg, J, Karlberg, B E, Jern, S, Hansson, L
Formato: Artigo
Idioma:Inglês
Publicado em: 1984
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1463665/
https://ncbi.nlm.nih.gov/pubmed/6152175
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados